Abdiyeva K, Turebekov N, Yegemberdiyeva R, Dmitrovskiy A, Yeraliyeva L, Shapiyeva Z, Nurmakhanov T, Sansyzbayev Y, Froeschl G, Hoelscher M, Zinner J, Essbauer S, Frey S. 2020. Vectors, molecular epidemiology and phylogeny of TBEV in Kazakhstan and central Asia. Parasites & Vectors, 13, 504. (in English)

Balke I, Zeltins A. 2019. Use of plant viruses and virus-like particles for the creation of novel vaccines. Advanced Drug Delivery Reviews, 145, 119-129. (in English)

Blazevic J, Rouha H, Bradt V, Heinz F X, Stiasny K. 2016. Membrane Anchors of the Structural Flavivirus Proteins and Their Role in Virus Assembly. Journal of Virology, 90, 6365-6378. (in English)

Bogovic P, Strle F. 2015. Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management. World Journal of Clinical Cases, 3, 430-441. (in English)

Bungener L, Geeraedts F, Ter Veer W, Medema J, Wilschut J, Huckriede A. 2008. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection. Vaccine, 26, 2350-2359. (in English)

Chong H Y, Leow C Y, Abdul Majeed A B, Leow C H. 2019. Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis. Virus Research, 274, 197770. (in English)

Cox R J, Brokstad K A. 2020. Not just antibodies: B cells and T cells mediate immunity to COVID-19. Nature Reviews Immunology, 20, 581-582. (in English)

Cuddapah S, Barski A, Zhao K. 2010. Epigenomics of T cell activation, differentiation, and memory. Current Opinion In Immunology, 22, 341-347. (in English)

Dai X, Shang G, Lu S, Yang J, Xu J. 2018. A new subtype of eastern tick-borne encephalitis virus discovered in Qinghai-Tibet Plateau, China. Emerging Microbes & Infections, 7, 74. (in English)

Demina T V, Dzhioev Y P, Verkhozina M M, Kozlova I V, Tkachev S E, Plyusnin A, Doroshchenko E K, Lisak O V, Zlobin V I. 2010. Genotyping and characterization of the geographical distribution of tick-borne encephalitis virus variants with a set of molecular probes. Journal Of Medical Virology, 82, 965-976. (in English)

Dong L, Xiao J, Liu S, Deng G, Liao Y, Chu B, Zhao X, Song B L, Luo J. 2023. Lysosomal cholesterol accumulation is commonly found in most peroxisomal disorders and reversed by 2-hydroxypropyl-β-cyclodextrin. Science China-life Sciences, 66, 1786-1799. (in English)

Donoso Mantke O, Escadafal C, Niedrig M, Pfeffer M, Working Group For Tick-Borne Encephalitis Virus C. 2011. Tick-borne encephalitis in Europe, 2007 to 2009. Eurosurveillance, 16, 19976. (in English)

Esser H J, Lim S M, de Vries A, Sprong H, Dekker D J, Pascoe E L, Bakker J W, Suin V, Franz E, Martina B E E, Koenraadt C J M. 2022. Continued Circulation of Tick-Borne Encephalitis Virus Variants and Detection of Novel Transmission Foci, the Netherlands. Emerging Infectious Diseases, 28, 2416-2424. (in English)

Ewer K J, O'Hara G A, Duncan C J, Collins K A, Sheehy S H, Reyes-Sandoval A, Goodman A L, Edwards N J, Elias S C, Halstead F D, Longley R J, Rowland R, Poulton I D, Draper S J, Blagborough A M, Berrie E, Moyle S, Williams N, Siani L, Folgori A, Colloca S, Sinden R E, Lawrie A M, Cortese R, Gilbert S C, Nicosia A, Hill A V. 2013. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. Nature Communications, 4, 2836. (in English)

Fares W, Dachraoui K, Cherni S, Barhoumi W, Slimane T B, Younsi H, Zhioua E. 2021. Tick-borne encephalitis virus in Ixodes ricinus (Acari: Ixodidae) ticks, Tunisia. Ticks and Tick-borne Diseases, 12, 101606. (in English)

Fritz R, Orlinger K K, Hofmeister Y, Janecki K, Traweger A, Perez-Burgos L, Barrett P N, Kreil T R. 2012. Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes. Vaccine, 30, 1165-1169. (in English)

Fuzik T, Formanova P, Ruzek D, Yoshii K, Niedrig M, Plevka P. 2018. Structure of tick-borne encephalitis virus and its neutralization by a monoclonal antibody. Nature Communications, 9, 436. (in English)

Gebre M S, Brito L A, Tostanoski L H, Edwards D K, Carfi A, Barouch D H. 2021. Novel approaches for vaccine development. Cell, 184, 1589-1603. (in English)

Girgsdies O E, Rosenkranz G. 1996. Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study. Vaccine, 14, 1421-1428. (in English)

Jin H, Bai Y, Wang J, Jiao C, Liu D, Zhang M, Li E, Huang P, Gong Z, Song Y, Xu S, Feng N, Zhao Y, Wang T, Li N, Gao Y, Yang S, Zhang H, Li Y, Xia X, Wang H. 2022. A bacterium-like particle vaccine displaying Zika virus prM-E induces systemic immune responses in mice. Transboundary and Emerging Diseases, 69, e2516-e2529. (in English)

Kent S J, Khoury D S, Reynaldi A, Juno J A, Wheatley A K, Stadler E, John Wherry E, Triccas J, Sasson S C, Cromer D, Davenport M P. 2022. Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast? Nature Reviews Immunology, 22, 387-397. (in English)

Kollaritsch H, Paulke-Korinek M, Holzmann H, Hombach J, Bjorvatn B, Barrett A. 2012. Vaccines and vaccination against tick-borne encephalitis. Expert review of vaccines, 11, 1103-1119. (in English)

Krol E, Brzuska G, Szewczyk B. 2019. Production and Biomedical Application of Flavivirus-like Particles. Trends in Biotechnology, 37, 1202-1216. (in English)

Kubinski M, Beicht J, Gerlach T, Volz A, Sutter G, Rimmelzwaan G F. 2020. Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise. Vaccines (Basel), 8, 451. (in English)

Kunz C, Hofmann H, Stary A. 1976. Feldversuche mit einem Impfstoff gegen die Frühsommer-Meningoenzephalitis (FSME) [Field studies with a new tick-borne encephalitis (TBE) vaccine]. Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie, 234, 141-144. (in English)

Li J X, Wu S P, Guo X L, Tang R, Huang B Y, Chen X Q, Chen Y, Hou L H, Liu J X, Zhong J, Pan H X, Shi F J, Xu X Y, Li Z P, Zhang X Y, Cui L B, Tan W J, Chen W, Zhu F C. 2022. Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial. Lancet Respiratory Medicine, 10, 739-748. (in English)

Lim J M E, Hang S K, Hariharaputran S, Chia A, Tan N, Lee E S, Chng E, Lim P L, Young B E, Lye D C, Le Bert N, Bertoletti A, Tan A T. 2022. A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines. Cell Reports Medicine, 3, 100793. (in English)

Liu Y, Zeng Q, Deng C, Li M, Li L, Liu D, Liu M, Ruan X, Mei J, Mo R, Zhou Q, Liu M, Peng S, Wang J, Zhang H, Xiao H. 2022. Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine. Cell Discovery, 8, 10. (in English)

Loew-Baselli A, Konior R, Pavlova B G, Fritsch S, Poellabauer E, Maritsch F, Harmacek P, Krammer M, Barrett P N, Ehrlich H J. 2006. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies. Vaccine, 24, 5256-5263. (in English)

Luo Y, Guo X, Yan H, Fang D, Zeng G, Zhou J, Jiang L. 2015. Comprehensive mapping infection-enhancing epitopes of dengue pr protein using polyclonal antibody against prM. Applied Microbiology and Biotechnology, 99, 5917-5927. (in English)

Mansfield K L, Horton D L, Johnson N, Li L, Barrett A D T, Smith D J, Galbraith S E, Solomon T, Fooks A R. 2011. Flavivirus-induced antibody cross-reactivity. Journal of General Virology, 92, 2821-2829. (in English)

Nooraei S, Bahrulolum H, Hoseini Z S, Katalani C, Hajizade A, Easton A J, Ahmadian G. 2021. Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. Journal of Nanobiotechnology, 19, 59. (in English)

Orlinger K K, Hofmeister Y, Fritz R, Holzer G W, Falkner F G, Unger B, Loew-Baselli A, Poellabauer E M, Ehrlich H J, Barrett P N, Kreil T R. 2011. A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans. Journal of Infectious Diseases, 203, 1556-1564. (in English)

Palomino-Tapia V A, Zavala G, Cheng S, García M. 2019. Long-term protection against a virulent field isolate of infectious laryngotracheitis virus induced by inactivated, recombinant, and modified live virus vaccines in commercial layers. Avian Pathology, 48, 209-220. (in English)

Pierson T C, Fremont D H, Kuhn R J, Diamond M S. 2008. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host & Microbe, 4, 229-238. (in English)

Prymula R, Pöllabauer E M, Pavlova B G, Löw-Baselli A, Fritsch S, Angermayr R, Geisberger A, Barrett P N, Ehrlich H J. 2012. Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior. Human Vaccines & Immunotherapeutics, 8, 736-742. (in English)

Rawat K, Kumari P, Saha L. 2021. COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies. European Journal of Pharmacology, 892, 173751. (in English)

Ruzek D, Avsic Zupanc T, Borde J, Chrdle A, Eyer L, Karganova G, Kholodilov I, Knap N, Kozlovskaya L, Matveev A, Miller A D, Osolodkin D I, Overby A K, Tikunova N, Tkachev S, Zajkowska J. 2019. Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines. Antiviral Research, 164, 23-51. (in English)

Salvo M A, Kingstad-Bakke B, Salas-Quinchucua C, Camacho E, Osorio J E. 2018. Zika virus like particles elicit protective antibodies in mice. PLoS Neglected Tropical Diseases, 12, e0006210. (in English)

Slunge D, Boman A, Studahl M. 2022. Burden of Tick-Borne Encephalitis, Sweden. Emerging Infectious Diseases, 28, 314-322. (in English)

Süss J. 2011. Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia-an overview. Ticks and Tick-borne Diseases, 2, 2-15. (in English)

Taba P, Schmutzhard E, Forsberg P, Lutsar I, Ljostad U, Mygland A, Levchenko I, Strle F, Steiner I. 2017. EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis. European Journal of Neurology, 24, 1214-e1261. (in English)

Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, Mayhew S. 2020. The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery, 19, 305-306. (in English)

Xing Y, Schmitt H J, Arguedas A, Yang J. 2017. Tick-borne encephalitis in China: A review of epidemiology and vaccines. Vaccine, 35, 1227-1237. (in English)

Zhang H, Jin H, Yan F, Song Y, Dai J, Jiao C, Bai Y, Sun J, Liu D, Wang S, Zhang M, Lu J, Huang J, Huang P, Li Y, Xia X, Wang H. 2022. An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV. Virologica Sinica, 38, 244–256. (in English)

Zhang M, Jin H, Li Y, Jiao C, Huang P, Bai Y, Gong Z, Zhang H, Liu S, Wang H. 2023. Genetically engineered bacterial‐like particles induced specific cellular and humoral immunity as effective tick‐borne encephalitis virus vaccine. Aggregate, 4, 305. (in English)

Zhang N, Li C, Jiang S, Du L. 2020. Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines. Vaccines (Basel), 8, 481. (in English)

Zhang X, Cui Z. 2023. Nanoparticle-Based Vaccines against Zoonotic Viruses: A Review. Zoonoses, 3, 47. (in English)

Zimna M, Brzuska G, Salát J, Svoboda P, Baranska K, Szewczyk B, Růžek D, Krol E. 2023. Functional characterization and immunogenicity of a novel vaccine candidate against tick-borne encephalitis virus based on Leishmania-derived virus-like particles. Antiviral Research, 209, 105511. (in English)

Zlatkovic J, Stiasny K, Heinz F X. 2011. Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice. Journal of Virology, 85, 1994-2003. (in English)